Invesaro

Stocks IFF Financial statements

Financial statements

INTERNATIONAL FLAVORS & FRAGRANCES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data INTERNATIONAL FLAVORS & FRAGRANCES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3,1163,3993,9785,1405,08411,65612,44011,47911,48410,890
Cost of revenue1,7211,9262,2953,0272,9987,9218,2897,7987,3606,952
Gross profit1,3961,4721,6832,1132,0863,7354,1513,6814,1243,938
Research and development259295312346357629603636671694
Selling, general and administrative5735707078769491,7491,7681,7871,9951,834
Operating income553553584665566585-1,326-2,110766-382
Interest expense5365.4133138132289336380305229
Interest income81551519
Other non-operating income23.849.835.23075826-5-182-65
Pre-tax income524537448557441354-1,625-2,518308-412
Income tax1192411089774752396941-53
Net income to minority interests002.484497442
Net income405296340456363270-1,871-2,591263-361
EBITDA6556717589888911,741-147-9681,781580
EPS, basic5.073.733.814.053.251.11-7.32-10.141.04-1.41
EPS, diluted5.053.723.794.003.211.10-7.32-10.141.04-1.41
Shares, basic (weighted)79.679.187.6112112243255255256256
Shares, diluted (weighted)8079.488.1113114243255255256256
Dividend per share2.402.662.842.963.043.123.203.241.601.60

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents324368635607650711483703469590
Receivables55166463.58769291,9061,8181,7261,6241,294
Inventory5926491,0791,1231,1322,5163,1512,4772,1331,507
Other current assets142215277319342728770875686742
Total current assets1,6091,8972,9422,9433,0606,9877,4326,2937,9685,594
Property, plant and equipment7768811,2411,3871,4584,3684,2034,2403,7392,685
Lease right-of-use assets0288299767743689589515
Goodwill1,0001,1565,3785,4975,59316,43213,37310,6359,0758,226
Intangible assets3664163,0392,8522,72710,5069,0828,3576,4453,964
Other non-current assets128250289608418616689764907954
Total assets4,0174,59912,88913,28713,55539,65835,52230,97828,72325,539
Accounts payable2753384715105561,5321,4181,3781,283933
Accrued liabilities64.488.4121103133335267265420259
Deferred revenue1.0111.14.94
Short-term debt2596.9748.63856343084108851,4131,254
Total current liabilities8987691,1281,5521,9043,6333,7283,7584,3523,933
Long-term debt1,0671,6324,5043,9973,77910,76810,3739,1867,5644,738
Lease liabilities253265670672642550533
Other non-current liabilities137191248502268462491560627573
Total liabilities2,3862,9106,8467,0587,23318,54117,87516,39814,85411,353
Total debt1,3251,6394,5954,4174,44410,97110,5809,9808,8915,637
Paid-in capital1521633,7943,8233,85319,82619,84119,87419,91719,918
Retained earnings3,8193,8713,9564,1184,1563,641955-2,439-2,647-3,417
Treasury stock-1,679-1,726-1,031-1,023-1,017-997-978-963-944-952
Other comprehensive income-680-637-702-717-698-1,423-2,198-1,896-2,527-1,430
Shareholders' equity1,6261,6846,0336,2176,31021,08217,65514,61113,83414,154
Minority interests4.895.0910.412.2123530313532
Total equity1,6311,6896,0436,2296,32221,11717,64714,58013,86914,186
Total liabilities and equity4,0174,59912,88913,28713,55539,65835,52230,97828,72325,539
Shares outstanding79.278.9107107107255255255256256

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income405296340460367279-1,864-2,587267-359
Depreciation and amortization1021181743233251,1561,1791,1421,015962
Stock-based compensation24.626.629.434365449657788
Deferred income tax14.458.919.4-59-68-236-237-371-323-270
Change in receivables-21.5-68.9-5060-61-169-11751-217-68
Change in inventory15.5-18.9-118-6218-363-893605-34-41
Change in payables-7.6429.155.15528419-57-3940-57
Cash from operations5503914386997141,4373971,4551,070850
Capital expenditures-126-129-170-236-192-393-504-503-463-594
Acquisitions-237-192-4,857-4900-11000
Cash from investing-355-300-5,013-226-187-187455583262,269
Debt issued5564983,2570200300
Debt repaid-125-250-377-155-347-828-300-655-1,030-2,913
Share buybacks-127-58.1-15.50000-38
Dividends paid-185-206-230-314-323-667-810-826-514-409
Cash from financing-34.4-42.64,871-505-512-1,304-1,229-1,851-1,606-3,091
Exchange rate effect-18.2-4.21-14.6721-59-7721-5491
Net change in cash14244.1280-253656-164183-264119
Free cash flow4242622674635221,044-107952607256
Interest paid50.655.4118134128310310370308229
Income taxes paid108107116126133289329578370329

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $85.69 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin36.5%Gross profit / revenue.
Operating margin7.5%Operating income / revenue.
EBITDA margin13.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin3.2%Pre-tax income / revenue.
Net margin2.6%Net income / revenue.
FCF margin5.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin10.7%Cash from operations / revenue.
Effective tax rate21.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)2.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)1.1%Net income / average total assets.
Return on invested capital (ROIC)3.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue6.3%Research and development expense / revenue.
SG&A / revenue16.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue5.7%Capital expenditures / revenue.
D&A / revenue6.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-5.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-4.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y16.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-4.5%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-1.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y13.6%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-149.9%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-67.4%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y-8.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-237.3%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-235.6%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y-20.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y28.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y3.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-57.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y-13.3%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y-20.6%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y-12.0%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y2.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-7.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y17.5%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-11.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-10.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y13.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y17.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.06xCurrent assets / current liabilities.
Quick ratio0.45x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.13x(Cash + short-term investments) / current liabilities.
Debt / equity0.41xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets22.7%Total debt / total assets.
Liabilities / assets44.3%Total liabilities / total assets.
Net debt$5.13BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.50xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$4.68BCurrent assets - current liabilities.
Goodwill and intangibles / assets47.2%(Goodwill + intangible assets) / total assets.
Tangible book value$2.10BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.43xRevenue / average total assets.
Fixed asset turnover4.06xRevenue / average property, plant and equipment.
Inventory turnover4.14xCost of revenue / average inventory.
Days inventory88 days365 x average inventory / cost of revenue.
Receivables turnover7.60xRevenue / average receivables.
Days sales outstanding48 days365 x average receivables / revenue.
Days payables62 days365 x average accounts payable / cost of revenue.
Cash conversion cycle74 daysDays inventory + days sales outstanding - days payables.
FCF conversion194.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow53.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.08Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$42.11Revenue / diluted weighted shares.
FCF per share$2.10Free cash flow / diluted weighted shares.
Operating cash flow per share$4.52Cash from operations / diluted weighted shares.
Book value per share$54.74Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$8.22Tangible book value / shares outstanding.
Cash per share$2.23(Cash + short-term investments) / shares outstanding.
Payout ratio147.7%Dividends paid / net income, when net income is positive.
Dividends / FCF75.7%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$21.86BShare price x shares outstanding.
Enterprise value$26.99BMarket cap + total debt - cash - short-term investments.
P/E78.9xMarket cap / net income. Only when net income is positive.
P/S2.02xMarket cap / revenue.
P/B1.56xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book10.4xMarket cap / tangible book value, when positive.
P/FCF40.5xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF18.8xMarket cap / cash from operations, when positive.
EV/Sales2.49xEnterprise value / revenue.
EV/EBIT33.3xEnterprise value / operating income, when both are positive.
EV/EBITDA18.4xEnterprise value / EBITDA, when both are positive.
EV/FCF50.0xEnterprise value / free cash flow, when both are positive.
FCF yield2.5%Free cash flow / market cap.
Earnings yield1.3%Net income / market cap (the inverse of P/E).
Dividend yield1.9%Dividends paid over the period / market cap.
Shareholder yield1.9%(Dividends paid + share buybacks) / market cap.
What was INTERNATIONAL FLAVORS & FRAGRANCES INC's revenue in fiscal 2025?

INTERNATIONAL FLAVORS & FRAGRANCES INC reported revenue of $10.89B for fiscal 2025, 5.2% lower than the year before.

Was INTERNATIONAL FLAVORS & FRAGRANCES INC profitable in fiscal 2025?

No. It reported a net loss of $361.0M.

How much free cash flow did INTERNATIONAL FLAVORS & FRAGRANCES INC generate in fiscal 2025?

Cash from operations of $850.0M minus capital expenditures of $594.0M left free cash flow of $256.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to INTERNATIONAL FLAVORS & FRAGRANCES INC